Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The European Commission has approved AbbVie?s hepatitis C treatment, called Viekirax (ombitasvir/ paritaprevir/ritonavir) and Exviera (dasabu...
Bristol-Myers Squibb has decided to end its pursuit of an approval for the hepatitis C therapy asunaprevir in the United States.
Following the release of newer, improved therapies to treat hepatitis C, Vertex has decided to discontinue Incivek (telaprevir).
UnitedHealth Group, the nation’s largest insurer, paid $100 million for hepatitis C medications during the first quarter of the year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.